
MHRA new recognition routes to access to new medicines
After Brexit the MHRA had been preparing to take over the role of sole approver of newly licensed medicines in the UK until now.
After Brexit the MHRA had been preparing to take over the role of sole approver of newly licensed medicines in the UK until now.
At the recent MHRA GDP Symposium held in February the inspectorate announced a change to the MHRA inspection process.
UK Pharmacists and Pharmacies have received communication for the Royal Pharmaceutical Society yesterday (15th December 2022) regarding the addition of 3 penicillin products to the list of products impacted by serious shortages in supply.
MHRA Guidance Note 6 – Notes for applicants and holders of a Wholesale Dealer’s Licence (WDA(H)) or Broker Registration was updated in November 2022 with some significant changes regarding Brexit.
Many clients contact us for information and help on expanding the scope of their WDA license to include the ability to export UK licensed medicinal products without necessarily understanding the challenges of exporting UK licensed medicinal products.